NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Short-term Investments (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Short-term Investments came in at $47000.0 in Q4 2025, up 34.29% year-over-year from $35000.0 in Q4 2024, and up 9.3% quarter-over-quarter from $43000.0 in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Short-term Investments (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Short-term Investments across 6 years of filings, most recently posting $47000.0 for Q4 2025.

  • In Q4 2025, Short-term Investments rose 34.29% year-over-year to $47000.0; the TTM figure through Dec 2025 stood at $47000.0 (up 34.29% YoY), while the FY2025 annual figure was $47000.0, up 34.29% from the prior year.
  • Short-term Investments came in at $47000.0 for Q4 2025 at NeuroSense Therapeutics, up from $43000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $64000.0 in Q1 2022 to a low of -$20000.0 in Q4 2022.
  • Average Short-term Investments over 5 years is $31400.0, with a median of $36000.0 recorded in 2024.
  • Year-over-year, Short-term Investments tumbled 151.28% in 2022 and surged 1266.67% in 2024.
  • Over 5 years, Short-term Investments stood at $39000.0 in 2021, then plunged by 151.28% to -$20000.0 in 2022, then jumped by 85.0% to -$3000.0 in 2023, then surged by 1266.67% to $35000.0 in 2024, then jumped by 34.29% to $47000.0 in 2025.
  • Per Business Quant data, the three most recent Short-term Investments figures were $47000.0 in Q4 2025, $43000.0 in Q2 2025, and $35000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 47,000.00
Jun 30, 2025 43,000.00
Dec 31, 2024 35,000.00
Sep 30, 2024 35,000.00
Jun 30, 2024 35,000.00
Mar 31, 2024 36,000.00
Dec 31, 2023 -3,000.00
Sep 30, 2023 37,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 39,000.00
Dec 31, 2022 -20,000.00
Sep 30, 2022 23,000.00
Jun 30, 2022 23,000.00
Mar 31, 2022 64,000.00
Dec 31, 2021 39,000.00
Dec 31, 2020 37,000.00
API Access

NeuroSense Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=NRSN&period=max&api_key=YOUR_API_KEY